Navigation Links
Dipexium Pharmaceuticals Reports Second Quarter 2014 Financial and Operational Results
Date:8/12/2014

NEW YORK, Aug. 12, 2014 /PRNewswire/ -- Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, topical antibiotic peptide, today reported its financial results for the second quarter ended June 30, 2014 and provided an update on operational progress.

"The first half of 2014 has been an exciting period for Dipexium. We are very pleased with the progress achieved since the completion of our Initial Public Offering in March," stated David P. Luci, President & Chief Executive Officer of Dipexium. "Importantly, we remain on our stated timeline to complete enrollment in the OneStep-1 and OneStep-2 pivotal Phase 3 clinical trials in the first quarter of 2015 and file a New Drug Application (NDA) for Locilex® in the second half of 2015."

Financial Results for the Second Quarter of 2014For the three months ended June 30, 2014, Dipexium reported a net loss of approximately $3.9 million, compared to $0.4 million for the three months ended June 30, 2013, an increase of $3.5 million, primarily due to a $2.5 million increase in research and development expenses and a $1.0 million increase in general and administrative expenses. The increased research and development expenses were primarily due to an increase of $1.9 million in research and development consulting-related expenses for the planning and execution of Locilex®'s Phase 1 and 3 clinical trials and a $0.6 million increase in research and development manufacturing costs related to manufacturing Locilex® for clinical trials. The increase in general and administrative expenses is primarily attributable to an increase of $0.7 million for compensation related expenses and an increase in $0.3 million in professional fees and office expenses.

For the six months end
'/>"/>

SOURCE Dipexium Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Valeant Pharmaceuticals Receives FTC Second Request Under Hart-Scott-Rodino
2. Rock Creek Pharmaceuticals Reports Second Quarter and Announces Clinical Update
3. AcelRx Pharmaceuticals Reports Second Quarter 2014 Financial Results
4. Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results
5. Absorption Pharmaceuticals CEO Jeff Abraham Discusses Promescent on KFI
6. Global Diabetic Neuropathy Market 2014-2018: Key Vendors are Eli Lilly and Co, Janssen Pharmaceuticals and Pfizer Inc.
7. Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes
8. AcelRx Pharmaceuticals to Participate in Three Upcoming Investor Events
9. Global Transdermal Drug Delivery Market 2014-2018: Key Vendors are ANI Pharmaceuticals, Antares Pharma, Bayer, Janssen and Novartis
10. Access Pharmaceuticals Announces European License Agreement With Norgine
11. Vanda Pharmaceuticals Reports Second Quarter 2014 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Saint-Gobain has acquired ZenPure, ... filtration products, mainly for the life sciences sector. ... in a state-of-the-art plant in Hangzhou, China ... the globe and will bolster the range of fluid ... acquisition is fully in line with the Group,s strategy ...
(Date:5/6/2015)...  Membership in Medicare Supplement plans continued to ... Strategy report released by Mark Farrah Associates (MFA).  ... Med Supp plans, covered approximately 11.2 million seniors ... from 2013. Between 2013 and 2014, enrollment in ... Though UnitedHealth was the segment growth leader, many ...
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/7qn2gf/global_insulin ) ... Insulin Patch Market Opportunity Analysis" report to ... ultrasound and iontophoresis are being used for the ... type of technique, their prices may vary which ... In long-term, it would be considered as inexpensive ...
Breaking Medicine Technology:Saint-Gobain Acquires ZenPure, a Specialist in Filtration Products 2Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2Global Insulin Patch Market Opportunity Analysis 2015 2
(Date:5/6/2015)... Lewisberry, PA (PRWEB) May 06, 2015 A quality ... option for a functional yet practical way to raise chickens on ... coop by Chicken Coop Condo, it will have a chicken tractor ... It will last for many years, as it is able to ... help control which areas of the land are fertilized, and it ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Chesapeake ... the state of Virginia to acquire Intuitive Surgical, ... robot. The system upgrade includes enhanced surgical technique ... invasive procedures across a wide spectrum of specialties. ... reduced pain and quicker recovery times. , “As ...
(Date:5/6/2015)... 2015 The Beryl Institute announces the ... Patient Experience Journal (PXJ), an international, open access, peer-reviewed ... and improving patient experience. The second volume of PXJ ... globally, helps align the voices engaged and provides the ... in association with The Beryl Institute, Volume 2, Issue ...
(Date:5/6/2015)... May 06, 2015 Is Colorado’s legal ... Next month the Centennial State will mark the 18-month ... sales to adults. And while Colorado’s legal marijuana industry ... that time, it’s also facing some new challenges. , ... currently facing shortages, especially in the wake of last ...
(Date:5/6/2015)... 2015 vcfo, a specialized consulting firm ... operational support to optimize business performance and productivity, announced ... and Michael Scheaffer. Both Lynch and Scheaffer have more ... , “We are delighted to add Jack and ... “Leveraging their background in financial management and leadership, Mike ...
Breaking Medicine News(10 mins):Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:vcfo Adds Two Senior Executives to Growing Team 2
... the President and CEO of the New Canadian EntityWHIPPANY, ... specialty pharmaceutical company, has announced today that it is ... Marketing (Canada) Ltd. This company will have its headquarters ... the marketing, sale and distribution of branded pharmaceutical products ...
... to "See the light on smokefree air"INDIANAPOLIS, March 3 ... today joined the fight to reduce the devastating effects ... legislators to pass a comprehensive smokefree law that protects ... leaders will march to the State House and assemble ...
... 3, 2009 UC Irvine neuroscientists have received $2 ... abilities. Study findings could lead to clinical research and ... autism. , UCI scientists hope to gain a greater ... located within the auditory cortex. , "We still don,t ...
... Misonix, Inc. (Nasdaq: MSON ), a ... in Europe is used for the ablation of tumors ... into a new, two year, sales agency agreement with ... for the representation of the Sonablate(R) SB500 High Intensity ...
... Center for Women and Justice at Cornell ... to End Violence Against Women Award-Winning Actress Reese Witherspoon ... One in three women worldwide experience violence in their ... every nine seconds(2). Around the world, services for victims ...
... SalesNOVATO, Calif., March 3 BioMarin Pharmaceutical Inc. (Nasdaq: ... warning letter issued to Genzyme addressing deficiencies related to ... in September and October 2008 has no foreseeable impact ... does not require Genzyme to recall or quarantine product. ...
Cached Medicine News:Health News:Halo Pharmaceutical Launches a Branded Product Marketing Company in Canada 2Health News:Indiana's Faith, Health Leaders Join Push for Comprehensive Smokefree Law 2Health News:Misonix Announces New Sales Agency Agreement for Eastern Europe 2Health News:Misonix Announces New Sales Agency Agreement for Eastern Europe 3Health News:Misonix Announces New Sales Agency Agreement for Eastern Europe 4Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 2Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 3Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 4Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 5Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 6Health News:FDA Warning Letter to Genzyme Related to the Allston Manufacturing Facility 2Health News:FDA Warning Letter to Genzyme Related to the Allston Manufacturing Facility 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: